Genes with relevance for early to late progression of colon carcinoma based on combined genomic and transcriptomic information from the same patients

Cancer Informatics

Volumn 9, Issue , 2010, Pages 79-91

  Lagerstedt, Kristina K ^a   Kristiansson, Erik ^b   Lönnroth, Christina ^a   Andersson, Marianne ^a   Iresjö, Britt Marie ^a   Gustafsson, Annika ^a   Hansson, Elisabeth ^c   Kressner, Ulf ^a   Nordgren, Svante ^a   Enlund, Fredrik ^a   Lundholm, Kent ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UDDEVALLA HOSPITAL   (Sweden)

Author keywords

CGH array; Colorectal cancer; microRNA; Transcription

Indexed keywords

MICRORNA; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CHROMOSOME 13; CHROMOSOME 20; CHROMOSOME 7; CHROMOSOME 8; CLINICAL ARTICLE; COLON CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENE INTERACTION; GENETIC ASSOCIATION; HUMAN; MALE; PROTEIN INTERACTION; TRANSCRIPTOMICS; UPREGULATION; CANCER STAGING; COLON CARCINOGENESIS; DNA EXTRACTION; DNA MICROARRAY; DNA TRANSCRIPTION; GENOME-WIDE ASSOCIATION STUDY; GENOMIC INSTABILITY; GENOMICS; HUMAN TISSUE; MIDDLE AGED; RNA EXTRACTION; TUMOR GROWTH; VERY ELDERLY;

EID: 77952898487     PISSN: 11769351     EISSN: 11769351     Source Type: Journal    
DOI: 10.4137/cin.s4545     Document Type: Article

References (56)

1. Frohling S, Dohner H. Chromosomal abnormalities in cancer. N Engl J Med. 2008;359(7):722-34.
2. Timp W, Levchenko A, Feinberg AP. A new link between epigenetic progenitor lesions in cancer and the dynamics of signal transduction. Cell Cycle. 2009;8(3):383-90.
3. Irizarry RA, Ladd-Acosta C, Wen B, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue- specific CpG island shores. Nat Genet. 2009;41(2):178-86.
4. Nephew KP, Huang TH. Epigenetic gene silencing in cancer initiation and progression. Cancer Lett. 2003;190(2):125-33.
5. Yang L, Belaguli N, Berger DH. MicroRNA and Colorectal Cancer. World J Surg. 2009.
6. Lagerstedt K, Staaf J, Jönsson G, et al. Tumor genome wide DNA alterations assessed by array CGH in patients with poor and excellent survival following operation for colorectal cancer. Cancer Informatics. 2007;3:1-15.
7. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med. 2009;361(25):2449-60.
8. Ley TJ, Mardis ER, Ding L, et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature. 2008;456(7218): 66-72.
9. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature. 2009;458(7239):719-24.
10. R Development Core Team, R. Language and Environment for Statistical Computing; 2009.
11. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):R80
12. Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics. 2004;5(4):557-72.
13. Aguirre AJ, Brennan C, Bailey G, et al. High-resolution characterization of the pancreatic adenocarcinoma genome. proc Natl Acad Sci U S A. 2004;101(24):9067-72.
14. Yang YH, Dudoit S, Luu P, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 2002;30(4):e15.
15. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article3.
16. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Royal Statistical Soc. 1995;57(1):289-300.
17. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19(2):185-93.
18. Tsafrir D, Bacolod M, Selvanayagam Z, et al. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res. 2006;66(4):2129-37.
19. Habermann JK, Paulsen U, Roblick UJ, et al. Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis. Genes Chromosomes Cancer. 2007;46(1):10-26.
20. Hermsen M, Postma C, Baak J, et al. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology. 2002;123(4):1109-19.
21. Carvalho B, Postma C, Mongera S, et al. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut. 2009;58(1):79-89.
22. Bertucci F, Salas S, Eysteries S, et al. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene. 2004;23(7):1377-91.
23. Camps J, Grade M, Nguyen QT, Hormann P, Becker S, Hummon AB, et al. Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome. Cancer Res. 2008;68(5):1284-95.
24. Bertucci F, Finetti P, Rougemont J, Charafe-Jauffret E, Nasser V, Loriod B, et al. Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy. Cancer Res. 2004;64(23):8558-65.
25. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol. 2008;10(2):202-10.
26. Negrini M, Calin GA. Breast cancer metastasis: a microRNA story. Breast Cancer Res. 2008;10(2):203.
27. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008;299(4):425-36.
28. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, Dyrskjot L, et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res. 2008;68(15):6416-24.
29. Monzo M, Navarro A, Bandres E, Artells R, Moreno I, Gel B, et al. Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res. 2008;18(8):823-33.
30. Kim S, Choi M, Cho KH. Identifying the target mRNAs of microRNAs in colorectal cancer. Comput Biol Chem. 2009;33(1):94-9.
31. Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N, et al. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer. 2006;5:29.
32. Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, et al. Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol. 2009;34(4):1069-75.
33. Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, et al. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer. 2009;9:374.
34. Hoeijmakers JH. DNA damage, aging, and cancer. N Engl J Med. 2009;361(15):1475-85.
35. Hewitt KJ, Agarwal R, Morin PJ. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer. 2006;6:186.
36. Morin PJ. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res. 2005;65(21):9603-6.
37. Jiang W, Li X, Rao S, Wang L, Du L, Li C, et al. Constructing disease- specific gene networks using pair-wise relevance metric: application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements. BMC Syst Biol. 2008;2:72.
38. Liu Y, Zhu X, Zhu J, Liao S, Tang Q, Liu K, et al. Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray. Oncol Rep. 2007;18(4):943-51.
39. Takashima N, Ishiguro H, Kuwabara Y, Kimura M, Haruki N, Ando T, et al. Expression and prognostic roles of PABPC1 in esophageal cancer: correlation with tumor progression and postoperative survival. Oncol Rep. 2006;15(3):667-71.
40. Carrasco DR, Tonon G, Huang Y, Zhang Y, Sinha R, Feng B, et al. High- resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell. 2006;9(4):313-25.
41. Savola S, Klami A, Tripathi A, Niini T, Serra M, Picci P, et al. Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors. BMC Cancer. 2009;9:17.
42. Cai B, Hogg D, Lu G, Liu L, Xi X, Xu W, et al. Studies of differential- expressed genes in human endometrial cancer of various differentiated grades. Chinese J Clin Oncol. 2007;4(2):77-82.
43. Lancaster JM, Dressman HK, Pittman J, Gray J, Sayer R, West M, et al. Identification of genes assosiated with ovarian cancer metastasis using microarray expression analysis. Int J Gyn Cancer. 2008;14(Suppl 1):24
44. Finch A, Metcalfe K, Lui J, Springate C, Demsky R, Armel S, et al. Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene. Clin Genet. 2009;75(3):220-4.
45. Daley D, Lewis S, Platzer P, MacMillen M, Willis J, Elston RC, et al. Identification of susceptibility genes for cancer in a genome-wide scan: results from the colon neoplasia sibling study. Am J Hum Genet. 2008;82(3):723-36.
46. Zhang PY, Zhang WG, He AL, Wang JL, Li WB. Identification and functional characterization of the novel acute monocytic leukemia associated antigen MLAA-34. Cancer Immunol Immunother. 2009;58(2):281-90.
47. Ko JM, Chan PL, Yau WL, Chan HK, Chan KC, Yu ZY, et al. Monochromo- some transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma. Mol Cancer Res. 2008;6(4):592-603.
48. Frank MJ, Dawson DW, Bensinger SJ, Hong JS, Knosp WM, Xu L, et al. Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human. B-cell lymphomas. Blood. 2009.
49. Fritzsche S, Kenzelmann M, Hoffmann MJ, Muller M, Engers R, Grone HJ, et al. Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma. Endocr Relat Cancer. 2006;13(3):839-49.
50. Tsavachidou D, Coleman ML, Athanasiadis G, Li S, Licht JD, Olson MF, et al. SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant. Cancer Res. 2004;64(16):5556-9.
51. Du JW, Gu JY, Liu J, Cen XN, Zhang Y, Ou Y, et al. TCR spectratyping revealed T lymphocytes associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma. 2007;48(8):1618-27.
52. Sun B, Wu J, Zhang T, Wang C. High-resolution analysis of genomic profiles of hepatocellular carcinoma cells with differential osteopontin expression. Cancer Biol Ther. 2008;7(3):387-91.
53. Grunhage F, Jungck M, Lamberti C, Keppeler H, Becker U, Schulte-Witte H, et al. Effects of common haplotypes of the ileal sodium dependent bile acid transporter gene on the development of sporadic and familial colorectal cancer: a case control study. BMC Med Genet. 2008;9:70.
54. Anderle P, Sengstag T, Mutch DM, Rumbo M, Praz V, Mansourian R, et al. Changes in the transcriptional profile of transporters in the intestine along the anterior-posterior and crypt-villus axes. BMC Genomics. 2005;6(1):69.
55. Smith SC, Nicholson B, Nitz M, Frierson HF, Jr, Smolkin M, et al. Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination. Am J pathol. 2009;174(2):371-9.
56. Strausberg RL, Feingold EA, Grouse LH, et al. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. proc Natl Acad Sci U S A. 2002;99(26):16899-903.